These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32001435)

  • 41. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.
    Almutairi MS; Gonzales-Luna AJ; Alnezary FS; Fallatah SB; Alam MJ; Begum K; Garey KW
    Anaerobe; 2021 Dec; 72():102440. PubMed ID: 34461273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring Clostridium difficile infection in an acute hospital: prevalence or incidence studies?
    Lavan AH; McCartan DP; Downes MM; Hill AD; Fitzpatrick F
    Ir J Med Sci; 2012 Sep; 181(3):315-20. PubMed ID: 22350440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Household Exposure to Primary Clostridioides difficile Infection With Secondary Infection in Family Members.
    Miller AC; Segre AM; Pemmaraju SV; Sewell DK; Polgreen PM
    JAMA Netw Open; 2020 Jun; 3(6):e208925. PubMed ID: 32589232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study.
    Dinh A; Le Monnier A; Emery C; Alami S; Torreton É; Duburcq A; Barbier F
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1297-1305. PubMed ID: 30941532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of a new methodology and R package reveals a high burden of healthcare-associated infections (HAI) in Germany compared to the average in the European Union/European Economic Area, 2011 to 2012.
    Zacher B; Haller S; Willrich N; Walter J; Abu Sin M; Cassini A; Plachouras D; Suetens C; Behnke M; Gastmeier P; Wieler LH; Eckmanns T
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.
    Fukuda H; Yano T; Shimono N
    Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection.
    Dubberke ER; Butler AM; Hota B; Khan YM; Mangino JE; Mayer J; Popovich KJ; Stevenson KB; Yokoe DS; McDonald LC; Jernigan J; Fraser VJ;
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):518-25. PubMed ID: 19419269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An emergent infectious disease: Clostridioides difficile infection hospitalizations, 10-year trend in Sicily.
    Medaglia AA; Buffa S; Gioè C; Bonura S; Rubino R; Iaria C; Colomba C; Cascio A
    Infection; 2021 Dec; 49(6):1221-1229. PubMed ID: 34495497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diverse sources of C. difficile infection identified on whole-genome sequencing.
    Eyre DW; Cule ML; Wilson DJ; Griffiths D; Vaughan A; O'Connor L; Ip CLC; Golubchik T; Batty EM; Finney JM; Wyllie DH; Didelot X; Piazza P; Bowden R; Dingle KE; Harding RM; Crook DW; Wilcox MH; Peto TEA; Walker AS
    N Engl J Med; 2013 Sep; 369(13):1195-205. PubMed ID: 24066741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surveillance of Clostridium difficile Infections: Results from a Six-Year Retrospective Study in Nine Hospitals of a North Italian Local Health Authority.
    Roncarati G; Dallolio L; Leoni E; Panico M; Zanni A; Farruggia P
    Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28075419
    [No Abstract]   [Full Text] [Related]  

  • 51. Epidemiology and Outcomes of Patients With Healthcare Facility-Onset Clostridioides difficile Infection.
    Eberly MD; Susi A; Adams DJ; Love CS; Nylund CM
    Mil Med; 2022 Jul; 187(7-8):e915-e920. PubMed ID: 33772561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of Clostridium difficile infection clusters, using the temporal scan statistic, in a community hospital in southern Ontario, Canada, 2006-2011.
    Faires MC; Pearl DL; Ciccotelli WA; Berke O; Reid-Smith RJ; Weese JS
    BMC Infect Dis; 2014 May; 14():254. PubMed ID: 24885351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clostridioides difficile infection-associated cause-specific and all-cause mortality: a population-based cohort study.
    Boven A; Vlieghe E; Engstrand L; Andersson FL; Callens S; Simin J; Brusselaers N
    Clin Microbiol Infect; 2023 Nov; 29(11):1424-1430. PubMed ID: 37473840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: the RECUR Germany study.
    Antunes A; Tricotel A; Wilk A; Dombrowski S; Rinta-Kokko H; Andersson FL; Ghosh S
    BMC Infect Dis; 2024 May; 24(1):548. PubMed ID: 38822244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset.
    Sahrmann JM; Olsen MA; Stwalley D; Yu H; Dubberke ER
    Clin Infect Dis; 2023 Mar; 76(5):809-815. PubMed ID: 36285546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of Clostridium difficile infection and colonization in a tertiary hospital and elderly community of North-Eastern Peninsular Malaysia.
    Zainul NH; Ma ZF; Besari A; Siti Asma H; Rahman RA; Collins DA; Hamid N; Riley TV; Lee YY
    Epidemiol Infect; 2017 Oct; 145(14):3012-3019. PubMed ID: 28891459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study.
    Bouza E; Cobo J; Rodríguez-Hernández MJ; Salavert M; Horcajada JP; Iribarren JA; Obi E; Lozano V; Maratia S; Cuesta M; Uría E; Limón E
    Rev Esp Quimioter; 2021 Apr; 34(2):126-135. PubMed ID: 33618513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital.
    Morfin-Otero R; Garza-Gonzalez E; Aguirre-Diaz SA; Escobedo-Sanchez R; Esparza-Ahumada S; Perez-Gomez HR; Petersen-Morfin S; Gonzalez-Diaz E; Martinez-Melendez A; Rodriguez-Noriega E;
    Braz J Infect Dis; 2016; 20(1):8-13. PubMed ID: 26620948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology of
    Colomb-Cotinat M; Assouvie L; Durand J; Daniau C; Leon L; Maugat S; Soing-Altrach S; Gateau C; Couturier J; Arnaud I; Astagneau P; Berger-Carbonne A; Barbut F
    Euro Surveill; 2019 Aug; 24(35):. PubMed ID: 31481147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia.
    Al-Tawfiq JA; Rabaan AA; Bazzi AM; Raza S; Noureen M
    Am J Infect Control; 2020 Oct; 48(10):1152-1157. PubMed ID: 32122671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.